Skip to content

New Imaging Tools to Explore Impact of Bariatric Surgery on Pancreatic Lesions: PACHIBA- Bariatric Surg

New Imaging Tools to Explore Impact of Bariatric Surgery on Pancreatic Lesions: PACHIBA- Bariatric Surg

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04746703
Acronym
PACHIBA
Enrollment
25
Registered
2021-02-10
Start date
2021-02-10
Completion date
2023-09-16
Last updated
2026-08-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bariatric Surgery

Keywords

bariatric surgery, pancreatic parameters

Brief summary

The investigators propose an exploratory study aiming at assessing the impact of surgical bariatric treatment on the improvement of pancreatic lesions detected by MRI. Pancreatic MRI will be performed in severe-obese patients with a planned bariatric surgery, before and 6 months after bariatric surgery. To assess the impact of bariatric surgery on pancreatic Magnetic Resonance Imaging (MRI) parameters in severe-obese patients

Interventions

RADIATIONMagnetic Resonance Imaging

Pancreatic MRI will be performed in severe-obese patients with a planned bariatric surgery, before and 6 months after bariatric surgery.

Sponsors

Assistance Publique - Hôpitaux de Paris
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Intervention model description

The investigators propose an exploratory study aiming at assessing the impact of surgical bariatric treatment on the improvement of pancreatic lesions detected by MRI.

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Adults (aged 18 to 65 years) with a planned for bariatric surgery (sleeve gastrectomy) according to HAS criteria * Patients with severe obesity (BMI≥35)

Exclusion criteria

* Patients with problem of alcohol abuse (previous or current) * Patients with problems of understanding * Patients with previous acute or chronic pancreatitis * Patients with contraindication to MRI (active implantable medical devices, pacemaker, claustrophobia …) * Inability to undergo MRI due to weight excess * Pregnant or breastfeeding woman * Absence of free and informed consent * Non affiliation to a social security regime or CMU (Universal health coverage) * Patient under AME (State medical aid) * Patient deprived of freedom, subject under a legal protective measure * Patients who have already had bariatric surgery Secondary

Design outcomes

Primary

MeasureTime frameDescription
Quantitative MRI parameters6 months after inclusionPancreatic fat content

Secondary

MeasureTime frameDescription
Metabolic and anthropometric parameters before and after bariatric surgery6 months after inclusionBMI
lipids parameters6 months after inclusiontotal cholesterol, HDL, LDL, triglycerides

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 14, 2026